Addressing the Barriers to Pediatric Drug Development: Workshop Summary

✍ Scribed by Development, and Translation Forum on Drug Discovery, Institute of Medicine

Year: 2008
Tongue: English
Leaves: 65
Category: Library

⬇ Acquire This Volume

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishing Precompetitive Collaboratio

📁 Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development: Workshop Summary

✍ Roundtable on Translating Genomic-Based Research on Health, Institute of Medicin 📂 Library 📅 2011 🏛 National Academies Press 🌐 English

Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However,

Accelerating the Development of Biomarke

📁 Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary

✍ Development, and Translation Forum on Drug Discovery, Institute of Medicine 📂 Library 📅 2009 🏛 National Academies Press 🌐 English

Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a

Addressing the Threat of Drug-Resistant

📁 Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary

✍ Institute of Medicine 📂 Library 📅 2009 🏛 National Academies Press 🌐 English

Addressing the Threat of Drug-Resistant

📁 Addressing the Threat of Drug-Resistant Tuberculosis: A Realistic Assessment of the Challenge: Workshop Summary

✍ Institute of Medicine 📂 Library 📅 2009 🌐 English

Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's Forum on Dr

Genome-Based Therapeutics: Targeted Drug

📁 Genome-Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary

✍ Institute Of Medicine, Board On Health Sciences Policy, Roundtable on Translatin 📂 Library 📅 2012 🏛 NATL ACADEMY PR 🌐 English

<p>The number of new drug approvals has remained reasonably steady for the past 50 years at around 20 to 30 per year, while at the same time the total spending on health-related research and development has tripled since 1990. There are many suspected causes for this trend, including increases in re

International regulatory harmonization a

📁 International regulatory harmonization amid globalization of drug development : workshop summary

✍ Weisfeld, Victoria D.; Lustig, Tracy A. 📂 Library 📅 2013 🏛 National Academies Press 🌐 English

The past several decades have been a time of rapid globalization in the development, manufacture, marketing, and distribution of medical products and technologies. Increasingly, research on the safety and effectiveness of new drugs is being conducted in countries with little experience in regulation